LALPATHLAB.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (13 May 2024 @ 06:00):

Stats
Today's Volume	1.87M
Average Volume	267 918
Market Cap	206.88B
EPS	INR0 ( 2024-05-08 )
Next earnings date	( INR0 ) 2024-07-25
Last Dividend	INR12.00 ( 2023-08-11 )
Next Dividend	INR0 ( N/A )
P/E	62.96
ATR14	INR3.02 (0.12%)

Volume Correlation

Long: 0.36 (neutral)

Short: 0.48 (neutral)

Signal:(47.904) Neutral

Dr. Lal PathLabs Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dr. Lal PathLabs Limited Correlation - Currency/Commodity

0.11
( neutral )

0.40
( neutral )

-0.17
( neutral )

0.51
( weak )

0.02
( neutral )

Dr. Lal PathLabs Limited Financials

Annual	2022
Revenue:	INR20.17B
Gross Profit:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Revenue:	INR20.17B
Gross Profit:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Revenue:	INR20.87B
Gross Profit:	INR13.00B (62.31 %)
EPS:	INR41.70

FY	2021
Revenue:	INR15.81B
Gross Profit:	INR11.84B (74.88 %)
EPS:	INR35.33

Financial Reports:

No articles found.

Dr. Lal PathLabs Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR6.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR12.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Dr. Lal PathLabs Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.87 - low (50.00%) | Divividend Growth Potential Score: 3.05 - Decrease likely (39.08%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.45	2016-07-20
Last Dividend	INR12.00	2023-08-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR77.95	--
Avg. Dividend % Per Year	0.37%	--
Score	2.2	--
Div. Sustainability Score	2.87
Div.Growth Potential Score	3.05
Div. Directional Score	2.96	--

Next Divdend (Est)
(2024-06-10)

INR13.50 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.20

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.50	0.66%
2019	INR9.50	1.03%
2020	INR12.00	0.78%
2021	INR20.00	0.83%
2022	INR12.00	0.31%
2023	INR12.00	0.55%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SPIC.NS	Dividend Junior	2023-09-20	Annually	3	0.70%
MOTHERSON.NS	Dividend Junior	2023-08-11	Annually	23	0.63%
HEIDELBERG.NS	Dividend Knight	2023-09-20	Annually	8	3.48%
BHARTIARTL.NS	Dividend Junior	2023-08-11	Annually	16	0.25%
RATNAMANI.NS	Dividend Junior	2023-07-27	Annually	19	0.72%
KOLTEPATIL.NS	Dividend Junior	2023-08-11	Annually	17	0.52%
EPL.NS	Dividend Junior	2023-08-04	Annually	22	1.11%
ALICON.NS	Dividend Junior	2023-09-13	Annually	18	0.25%
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NESCO.NS	Dividend Junior	2023-07-28	Annually	17	0.40%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.190	1.500	9.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	15.29	1.000	5.45	5.45	[3 - 30]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
freeCashFlowPerShareTTM	28.46	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.684	1.000	1.929	1.929	[0.2 - 0.8]
operatingProfitMarginTTM	0.224	1.000	7.52	7.52	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.87

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	64.04	1.000	3.63	0	[1 - 100]
returnOnEquityTTM	0.190	2.50	9.36	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.46	2.00	0.514	10.00	[0 - 30]
dividendYielPercentageTTM	0.945	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.109	1.000	9.77	0	[0.1 - 0.5]
Total Score				3.05

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.